Collaboration on business challenges and innovations with regulatory documentation

On March 17, RWS hosted the Q Innovation Workshop in Basel, Switzerland, bringing together pharmaceutical industry leaders from around the world to collaborate on innovation and business challenges in the clinical and regulatory landscape. The interactive event provided a forum for in-depth discussions on structured content authoring, data management, AI automation, localization, and the future of regulatory documentation. Participants explored a wide range of topics, including digital transformation, cloud infrastructure, patient-centric content, and evolving translation requirements in global organizations. The workshop also addressed how life sciences companies can better align structured content and data strategies to enhance operational efficiency and regulatory compliance. Dan Herron from RWS started the workshop by discussing recent RWS research showing that 36% of executives see a danger of enterprise resources—that could be better deployed elsewhere—being diverted toward Gen AI.